Literature DB >> 19491728

Molecular karyotype of sporadic unilateral retinoblastoma tumors.

Arupa Ganguly1, Kim E Nichols, Gregory Grant, Eric Rappaport, Carol Shields.   

Abstract

BACKGROUND: Retinoblastoma (RB) is a childhood ocular malignancy associated with mutations in RB1, a tumor susceptibility gene. Inactivation of both copies of the RB1 gene in a retinal cell is followed by the sequential acquisition of additional genetic changes that define the course to tumor formation.
METHODS: To identify the genetic events that cooperate with loss of the RB1 gene function, we performed a whole genome sampling assay based on single nucleotide polymorphism genotyping. We used DNA isolated from 25 sporadic, unilateral RB tumors and matched blood samples.
RESULTS: Genomic profiles were analyzed to identify regions of loss of heterozygosity or amplification. Two major subclasses of RB tumors were defined by the presence (n = 18) or absence (n = 7) of loss of heterozygosity of chromosome 13. Loss of heterozygosity in most cases was the result of copy-neutral events caused by mitotic recombination and mitotic nondisjunction. Tumors harbored novel regions of amplification at 1q44, 3p25, 11q14, 11q25, 14q23, 15q21, 16p13, 17p11.2, 19q13, and 20q13, whereas regions of loss included 6q22, 7q21, and 21q2.
CONCLUSION: Whole genome sampling assay-based analysis of unilateral RB tumors revealed novel regions as significant. These minimum critical regions that are lost or amplified are expected to harbor genes that aid the process of tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19491728      PMCID: PMC2722034          DOI: 10.1097/IAE.0b013e3181a0be05

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  43 in total

1.  High-throughput variation detection and genotyping using microarrays.

Authors:  D J Cutler; M E Zwick; M M Carrasquillo; C T Yohn; K P Tobin; C Kashuk; D J Mathews; N A Shah; E E Eichler; J A Warrington; A Chakravarti
Journal:  Genome Res       Date:  2001-11       Impact factor: 9.043

Review 2.  Two genetic hits (more or less) to cancer.

Authors:  A G Knudson
Journal:  Nat Rev Cancer       Date:  2001-11       Impact factor: 60.716

3.  Minimal regions of chromosomal imbalance in retinoblastoma detected by comparative genomic hybridization.

Authors:  D Chen; B L Gallie; J A Squire
Journal:  Cancer Genet Cytogenet       Date:  2001-08

4.  Rearrangements involving the 13q chromosome arm committed to the progression of laryngeal squamous cell carcinoma.

Authors:  Maciej Kujawski; Malgorzata Rydzanicz; Maarit Sarlomo-Rikala; Krzysztof Szyfter
Journal:  Cancer Genet Cytogenet       Date:  2002-08

Review 5.  Retinoblastoma tumor suppressor and genome stability.

Authors:  Lei Zheng; Wen-Hwa Lee
Journal:  Adv Cancer Res       Date:  2002       Impact factor: 6.242

6.  Detection of chromosome imbalances in retinoblastoma by parallel karyotype and CGH analyses.

Authors:  A Mairal; E Pinglier; E Gilbert; M Peter; P Validire; L Desjardins; F Doz; A Aurias; J Couturier
Journal:  Genes Chromosomes Cancer       Date:  2000-08       Impact factor: 5.006

7.  Postenucleation adjuvant therapy in high-risk retinoblastoma.

Authors:  Santosh G Honavar; Arun D Singh; Carol L Shields; Anna T Meadows; Hakan Demirci; Jacqueline Cater; Jerry A Shields
Journal:  Arch Ophthalmol       Date:  2002-07

8.  Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma.

Authors:  Helen Dimaras; Vikas Khetan; William Halliday; Marija Orlic; Nadia L Prigoda; Beata Piovesan; Paula Marrano; Timothy W Corson; Ralph C Eagle; Jeremy A Squire; Brenda L Gallie
Journal:  Hum Mol Genet       Date:  2008-01-22       Impact factor: 6.150

9.  Comparative genomic hybridization of 49 primary retinoblastoma tumors identifies chromosomal regions associated with histopathology, progression, and patient outcome.

Authors:  Debra M Lillington; Judith E Kingston; Pietro G Coen; Elizabeth Price; John Hungerford; Paola Domizio; Bryan D Young; Zerrin Onadim
Journal:  Genes Chromosomes Cancer       Date:  2003-02       Impact factor: 5.006

10.  Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application.

Authors:  C Li; W Hung Wong
Journal:  Genome Biol       Date:  2001-08-03       Impact factor: 13.583

View more
  9 in total

Review 1.  Current update on retinoblastoma.

Authors:  Samuel K Houston; Timothy G Murray; Stacey Quintero Wolfe; Cristina E Fernandes
Journal:  Int Ophthalmol Clin       Date:  2011

Review 2.  The genomic landscape of retinoblastoma: a review.

Authors:  Brigitte L Thériault; Helen Dimaras; Brenda L Gallie; Timothy W Corson
Journal:  Clin Exp Ophthalmol       Date:  2013-05-22       Impact factor: 4.207

Review 3.  Overview of recurrent chromosomal losses in retinoblastoma detected by low coverage next generation sequencing.

Authors:  A J García-Chequer; A Méndez-Tenorio; G Olguín-Ruiz; C Sánchez-Vallejo; P Isa; C F Arias; J Torres; A Hernández-Angeles; M A Ramírez-Ortiz; C Lara; M L Cabrera-Muñoz; S Sadowinski-Pine; J C Bravo-Ortiz; G Ramón-García; J Diegopérez-Ramírez; G Ramírez-Reyes; R Casarrubias-Islas; J Ramírez; M A Orjuela; M V Ponce-Castañeda
Journal:  Cancer Genet       Date:  2015-12-15

4.  Differential gene expression profile of retinoblastoma compared to normal retina.

Authors:  Arupa Ganguly; Carol L Shields
Journal:  Mol Vis       Date:  2010-07-13       Impact factor: 2.367

5.  A Meta-Analysis of Retinoblastoma Copy Numbers Refines the List of Possible Driver Genes Involved in Tumor Progression.

Authors:  Irsan E Kooi; Berber M Mol; Maarten P G Massink; Marcus C de Jong; Pim de Graaf; Paul van der Valk; Hanne Meijers-Heijboer; Gertjan J L Kaspers; Annette C Moll; Hein Te Riele; Jacqueline Cloos; Josephine C Dorsman
Journal:  PLoS One       Date:  2016-04-26       Impact factor: 3.240

6.  miRNome landscape analysis reveals a 30 miRNA core in retinoblastoma.

Authors:  Blanca Elena Castro-Magdonel; Manuela Orjuela; Javier Camacho; Adda Jeanette García-Chéquer; Lourdes Cabrera-Muñoz; Stanislaw Sadowinski-Pine; Noé Durán-Figueroa; María de Jesús Orozco-Romero; Ana Claudia Velázquez-Wong; Adriana Hernández-Ángeles; Claudia Hernández-Galván; Citlali Lara-Molina; M Verónica Ponce-Castañeda
Journal:  BMC Cancer       Date:  2017-07-01       Impact factor: 4.430

7.  Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.

Authors:  Kathryn G Ewens; Tricia R Bhatti; Kimberly A Moran; Jennifer Richards-Yutz; Carol L Shields; Ralph C Eagle; Arupa Ganguly
Journal:  Cancer Med       Date:  2017-02-17       Impact factor: 4.452

8.  Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes.

Authors:  Irsan E Kooi; Berber M Mol; Maarten P G Massink; Najim Ameziane; Hanne Meijers-Heijboer; Charlotte J Dommering; Saskia E van Mil; Yne de Vries; Annemarie H van der Hout; Gertjan J L Kaspers; Annette C Moll; Hein Te Riele; Jacqueline Cloos; Josephine C Dorsman
Journal:  Sci Rep       Date:  2016-04-29       Impact factor: 4.379

9.  RNA-Sequencing of Primary Retinoblastoma Tumors Provides New Insights and Challenges Into Tumor Development.

Authors:  Sailaja V Elchuri; Swetha Rajasekaran; Wayne O Miles
Journal:  Front Genet       Date:  2018-05-17       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.